Fibromuscular dysplasia (FMD) involving the coronary arteries is an uncommon but important condition that can present as acute coronary syndrome, left ventricular dysfunction, or potentially sudden cardiac death. Although the classic angiographic "string of beads" that may be observed in renal artery FMD does not occur in coronary arteries, potential manifestations include spontaneous coronary artery dissection, distal tapering or long, smooth narrowing that may represent dissection, intramural hematoma, spasm, or tortuosity. Importantly, FMD must be identified in at least one other noncoronary arterial territory to attribute any coronary findings to FMD. Although there is limited evidence to guide treatment, many lesions heal spontaneously; thus, a conservative approach is generally preferred. The etiology is poorly understood, but there are ongoing efforts to better characterize FMD and define its genetic and molecular basis. This report reviews the clinical course of FMD involving the coronary arteries and provides guidance for diagnosis and treatment strategies. (J Am Coll Cardiol 2014;64:1033-46)
F ibromuscular dysplasia (FMD) is an arteriopathy distinct from atherosclerosis or vasculitis that may result in stenosis, aneurysm, dissection, or occlusion. It predominantly affects middleaged women but may occur at any age in both sexes (1, 2) . The renal, carotid, and vertebral arteries are most frequently involved, but FMD has been reported in virtually every artery in the body (1, 3, 4) . Although 
EPIDEMIOLOGY AND DEMOGRAPHICS
In 1965, Hill and Antonius (9) first reported the pathology and clinical histories of 2 patients with FMD and coronary artery involvement. However, in the 5 decades since this initial report, many descriptions of FMD involving the coronary arteries have been small autopsy series or case reports (10) . Clinically manifest FMD with coronary artery involvement is believed to be rare, but its true prevalence is unknown. This is partly due to a lack of specific coronary findings or symptoms before an acute event. Importantly, while a "string of beads" appearance can be diagnostic of FMD in the renal, carotid, and other arterial beds, this appearance rarely, if ever, occurs in the coronary arteries. Rather, as discussed later, most patients with coronary artery manifestations of FMD present with SCAD or smooth narrowing and are subsequently found to have typical FMD findings in the noncoronary arteries.
The demographics of patients with coronary artery manifestations of FMD are similar to those of patients with FMD in other locations.
The mean age at diagnosis of the first 447 patients enrolled in the U.S. Registry for FMD was 51.9 AE 13.1 years (range of 5 to 86 years), and 91% were female (2) .
Hypertension was the most common cardiovascular risk factor (71%) due to renal artery FMD, but other cardiovascular risk factors were infrequent (37.2% were current or past smokers, and 42% were being treated with a statin). In comparison, in a series of 7 patients diagnosed antemortem with coronary artery manifestations of FMD, all were women between 42 and 56 years of age (11) . Similarly, in a series of 50 patients with SCAD in which 86% had confirmed FMD, the mean age was 51 AE 9.6 years (range 31 to 84 years), and the cardiovascular risk profile was similar to that reported in the U.S. Registry for FMD (5) .
ETIOLOGY
Although various hypotheses have been proposed to explain the etiology of FMD in general and its coronary artery manifestations, the cause remains unknown.
Many of the reports speculating about the biological etiology were published decades ago, with few subsequently published reports. It is most likely that subjects with FMD carry a genetic predisposition, because 7% to 11% of first-degree relatives have FMD (2, 12, 13) . Further evidence that this is a genetically mediated disease was derived from the U.S. Registry for FMD, in which 53.5% of first-or second-degree relatives had a stroke (many before 60 years of age), 23 .5% had an aneurysm, and 19.8% died suddenly (2) .
On the basis of pedigree studies, some have suggested that FMD may be due to an autosomal dominant trait with variable penetrance (14, 15) . However, the ge- On the basis of the available evidence at present, the generally accepted consensus is that FMD is likely a multifactorial disease with varying contributions from genetic, gender/hormonal, and environmental influences (18) .
PATHOLOGY AND CLASSIFICATION
The histological appearance of renal artery FMD has been well characterized. In 1938, Leadbetter and Burkland (19) Table 1) . In this early report, the media was affected in 80% to 90% of cases, and medial fibroplasia was the most common medial subtype. Because of collagen deposition that is seen histologically in medial fibroplasia, areas of arterial stenosis and poststenotic dilation develop. This corresponds to the "string of beads" appearance on angiography that is classically associated with renal artery FMD (21) . Unlike the situation for renal artery FMD, reliable reports of the histological characteristics of FMD affecting the coronary arteries are essentially nonexistent and no histological classification system has been proposed.
Histopathologic classification played an early (and now somewhat historical) role in managing patients with FMD during the era pre-dating catheter-based endovascular interventions, when clinically significant lesions were managed surgically. In the contemporary era, most patients with FMD who undergo revascularization of the coronary artery (or any other affected arteries) do so via an endovascular approach.
Therefore, pathological specimens of vessels from patients with FMD are now rarely available (18) . This has led to the evolution of a newer FMD classification system on the basis of angiography (Table 1, Figure 1 ) (18, 20, 22) . Prior angiographic-pathological correlative studies showed that multifocal FMD ("string of beads") is associated with medial fibroplasia, whereas Notably, none were due to coronary manifestations of FMD; 3 of these deaths were due to malignancy, and 1 patient who died was lost to follow-up (34) . Although difficult to quantify, these angiographic features also have clinical prognostic significance. The Adapted with permission from Olin et al. (2) .
Abbreviation as in Table 1 .
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Coronary Manifestations of FMD carefully considered in the differential diagnosis (Table 4) . Although this is a congenital abnormality, most patients present after 30 years of age (74) . Angiography is the gold standard for diagnosis and shows systolic narrowing of the affected coronary artery that disappears during diastole ("the milking effect") (76) .
Intracoronary injection of nitroglycerin may cause the relative degree of stenosis to increase because the intramyocardial segment of the vessel is constrained and ramus intermedius (white arrow). (E and F) Intravascular ultrasound performed immediately after percutaneous intervention revealed a large intramural hematoma (asterisks) in the mid-distal left main artery (red arrow), which extended into the LAD artery (yellow arrow). Over the next 2 days, she continued to have intermittent chest pain and rising troponin levels; she therefore underwent a third cardiac catheterization and was found to have (G) new severe proximal narrowing of the left circumflex artery (white arrows) and an occluded first obtuse marginal artery (black arrow), with patent intervention sites. No further intervention was performed, and the patient improved with medical therapy over the following days. Transthoracic echocardiography revealed a mild-moderately decreased ejection fraction (46%), and she was ultimately discharged home on aspirin, clopidogrel, a beta-blocker, and an angiotensin-converting enzyme inhibitor. She has remained well for 1 month post-discharge and awaits formal evaluation for FMD. Abbreviations as in Figures 1 and 2 .
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Coronary Manifestations of FMD and unable to respond, while the other coronary segments dilate in response to nitroglycerin (77, 78) . 
FI GURE 6 Standing Waves
Arteriography of the axillary artery showing standing waves (arrows). Standing waves are due to catheter-induced spasm, and typically the administration of nitroglycerin will result in a normal-appearing artery. Note the regular oscillations that occur with standing waves, in contrast to the appearance of the "string of beads" (Figure 1 ), where the "beads" are larger than the normal caliber of the artery.
Michelis et al. Tables 1 and 3 .
On the basis of retrospective studies, the estimated incidence of SCAD detected on all coronary angiograms ranges from 0.07% to 1.1% (102, (110) (111) (112) . A beta-blocker may also be considered, with the rationale being that by reducing blood pressure and heart rate, beta-blocker therapy reduces coronary shear forces that may help to reduce the risk of further coronary dissection (99) . Concomitant hypertension, whether or not attributed to renal artery FMD, should be treated to goal (18) .
In unstable patients or those with active myocardial ischemia, an interventional approach may be required. Although angioplasty alone is preferred for renal artery FMD, intracoronary stent implantation is usually required in patients with SCAD. Care must be taken to avoid stent or vessel overdilation, because this may lead to propagation of coronary dissection at the stent edges. Therefore, avoiding high balloon inflation pressures and using smaller-sized stents may be advisable (38) . The use of adjunctive intracoronary imaging with IVUS or OCT during percutaneous coronary intervention can help to avoid balloon or stent oversizing, optimize stent placement, and minimize complications (38) . Coronary artery bypass graft surgery should be reserved for patients jason.kovacic@mountsinai.org.
